drugset
drugset / Trial / NCT02485041

Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg

NCT02485041 ↗

Phase 1 Completed 36 enrolled SK Chemicals Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

Healthy male volunteers were administered alone and in combination with dapoxetine 30mg mirodenafil 100mg for three times, respectively and the pharmacokinetic interaction was compared between the two drugs.

Timeline

Start
2014-11
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapoxetine Small molecule 30 mg Oral
Subject Mirodenafil Small molecule 100 mg Oral

Indications

No indication recorded.